SEATTLE GENETICS INC License Agreements
9 Contracts & Agreements
- License Agreement dated as of August 8, 2021 between RemeGen Co., Ltd. and Seagen Inc (Filed With SEC on September 21, 2021)
- Amendment No. 1 to License Agreement dated April 23, 2020 between Cascadian Therapeutics, Inc. and Array BioPharma, Inc (Filed With SEC on July 31, 2020)
- License Agreement between Cascadian Therapeutics, Inc. and Array BioPharma Inc. dated December 11, 2014 (Filed With SEC on April 26, 2018)
- DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on May 1, 2017)
- OPTION and LICENSE AGREEMENT (Filed With SEC on March 13, 2009)
- LICENSE AGREEMENT (Filed With SEC on August 9, 2005)
- AMENDMENT NO. 3 TO LICENSE AGREEMENT (Filed With SEC on November 10, 2004)
- PATENT LICENSE AGREEMENT between PROTEIN DESIGN LABS, INC. (Filed With SEC on May 10, 2004)
- LICENSE AGREEMENT (Filed With SEC on May 9, 2003)
